Cited by 305Cannabis and Cannabinoid ResearchForensic Toxicology and Drug AnalysisPsychedelics and Drug Studies

The DOI matches its Crossref record; 34 of the 34 references it cites were found in a registry or an index.

Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study

Open access

Morgan, Celia J. A., Schafer, Gráinne, Freeman, Tom P., Curran, H. Valerie·2010·British Journal of Psychiatry

Open this paper in CoChat — free account Open PDF

Abstract

BACKGROUND: The two main constituents of cannabis, cannabidiol and Δ(9)-tetrahydrocannabinol (THC), have opposing effects both pharmacologically and behaviourally when administered in the laboratory. Street cannabis is known to contain varying levels of each cannabinoid. AIMS: To study how the varying levels of cannabidiol and THC have an impact on the acute effects of the drug in naturalistic settings. METHOD: Cannabis users (n = 134) were tested 7 days apart on measures of memory and psychotomimetic symptoms, once while they were drug free and once while acutely intoxicated by their own chosen smoked cannabis. Using an unprecedented methodology, a sample of cannabis (as well as saliva) was collected from each user and analysed for levels of cannabinoids. On the basis of highest and lowest cannabidiol content of cannabis, two groups of individuals were directly compared. RESULTS: Groups did not differ in the THC content of the cannabis they smoked. Unlike the marked impairment in prose recall of individuals who smoked cannabis low in cannabidiol, participants smoking cannabis high in cannabidiol showed no memory impairment. Cannabidiol content did not affect psychotomimetic symptoms, which were elevated in both groups when intoxicated. CONCLUSIONS: The antagonistic effects of cannabidiol at the CB(1) receptor are probably responsible for its profile in smoked cannabis, attenuating the memory-impairing effects of THC. In terms of harm reduction, users should be made aware of the higher risk of memory impairment associated with smoking low-cannabidiol strains of cannabis like 'skunk' and encouraged to use strains containing higher levels of cannabidiol.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1192/bjp.bp.110.077503

Cites

34 of 34 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The Brief Psychiatric Rating Scale.
Overall, J. E., & Gorham, D. R. (1962) · Psychological Reports · doi:10.2466/pr0.1962.10.3.799 · Cited by 11,090
Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review.
Moore, T. H., Zammit, S., Lingford-Hughes, A., Barnes, T. R., Jones, P. B., Burke, M., & Lewis, G. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61162-3 · Cited by 2,224
The SPQ: A Scale for the Assessment of Schizotypal Personality Based on DSM-III-R Criteria
Raine, A. (1991) · Schizophrenia Bulletin · doi:10.1093/schbul/17.4.555 · Cited by 2,164
The diverse CB 1 and CB 2 receptor pharmacology of three plant cannabinoids: Δ 9 ‐tetrahydrocannabinol, cannabidiol and Δ 9 ‐tetrahydrocannabivarin
Pertwee, R. G. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707442 · Cited by 2,047
The endogenous cannabinoid system controls extinction of aversive memories
Marsicano, G., Wotjak, C. T., Azad, S. C., Bisogno, T., Rammes, G., Cascio, M. G., Hermann, H., Tang, J., Hofmann, C., Zieglgänsberger, W., et al. (2002) · Nature · doi:10.1038/nature00839 · Cited by 1,728
The Severity of Dependence Scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users
Gossop, M., Darke, S. G., Griffiths, P., Hando, J., Powis, B., Hall, W., & Strang, J. (1995) · Addiction · doi:10.1046/j.1360-0443.1995.9056072.x · Cited by 1,341
The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: Implications for psychosis
D'Souza, D. C., Perry, E., MacDougall, L., Ammerman, Y., Cooper, T., Wu, Y.-T., Braley, G., Gueorguieva, R., & Krystal, J. H. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300496 · Cited by 1,024
Rivermead Behavioural Memory Test
la Cour, P., & GALLAGHER, K. (1990) · Nordisk Psykologi · doi:10.1080/00291463.1990.10636996 · Cited by 992
Opposite Effects of Δ-9-Tetrahydrocannabinol and Cannabidiol on Human Brain Function and Psychopathology
Bhattacharyya, S., Morrison, P. D., Fusar-Poli, P., Martin-Santos, R., Borgwardt, S., Winton-Brown, T., Nosarti, C., O' Carroll, C. M., Seal, M., Allen, P., et al. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.184 · Cited by 680
Wechsler Test of Adult Reading
(2001) · PsycTESTS Dataset · doi:10.1037/t15180-000 · Cited by 616

Flagged first, then by citations

Show all 30 references

Research works printed but not linked: 5

10.1038/sj.npp.1300496 · DOI · Paper page
2006, Annual Report 2006: The State of the Drugs Problem in Europe
2009, Health Survey Findings for England 2008
Hardwick, 2008, Home Office Cannabis Potency Study
10.1016/j.biopsych.2006.08.027 · DOI

Sorted by citations

Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects.
Russo, E. B. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01238.x · Cited by 1,535
The endocannabinoid system and the brain.
Mechoulam, R., & Parker, L. A. (2013) · Annual Review of Psychology · doi:10.1146/annurev-psych-113011-143739 · Cited by 1,090
Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders.
Devinsky, O., Cilio, M. R., Cross, H., Fernandez‐Ruiz, J., French, J., Hill, C., Katz, R., Di Marzo, V., Jutras‐Aswad, D., Notcutt, W. G., et al. (2014) · Epilepsia · doi:10.1111/epi.12631 · Cited by 1,000
Effects of Cannabis Use on Human Behavior, Including Cognition, Motivation, and Psychosis: A Review
Volkow, N. D., Swanson, J. M., Evins, A. E., DeLisi, L. E., Meier, M. H., Gonzalez, R., Bloomfield, M. A. P., Curran, H. V., & Baler, R. (2016) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.3278 · Cited by 867
Cannabidiol as a Potential Treatment for Anxiety Disorders
Blessing, E., Steenkamp, M. M., Manzanares, J., & Marmar, C. R. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0387-1 · Cited by 752
Acute and Chronic Effects of Cannabinoids on Human Cognition—A Systematic Review
Broyd, S. J., van Hell, H. H., Beale, C., Yücel, M., & Solowij, N. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.12.002 · Cited by 674
Cannabis, a complex plant: different compounds and different effects on individuals
Atakan, Z. (2012) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125312457586 · Cited by 612
Are cannabidiol and Δ9‐tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review
McPartland, J. M., Duncan, M., Marzo, V. D., & Pertwee, R. G. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12944 · Cited by 552
Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment
Englund, A., Morrison, P. D., Nottage, J. F., Hague, D., Kane, F., Bonaccorso, S., Stone, J. M., Reichenberg, A., Brenneisen, R., Holt, D., et al. (2012) · Journal of Psychopharmacology · doi:10.1177/0269881112460109 · Cited by 479
Association of Cannabis With Cognitive Functioning in Adolescents and Young Adults: A Systematic Review and Meta-analysis
Scott, J. C., Slomiak, S. T., Jones, J. D., Rosen, A. F. G., Moore, T. M., & Gur, R. C. (2018) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2018.0335 · Cited by 391
Keep off the grass? Cannabis, cognition and addiction
Curran, H. V., Freeman, T. P., Mokrysz, C., Lewis, D. A., Morgan, C. J. A., & Parsons, L. H. (2016) · Nature reviews. Neuroscience · doi:10.1038/nrn.2016.28 · Cited by 389
Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid?
Fernández‐Ruíz, J., Sagredo, O., Pazos, M. R., García, C., Pertwee, R. G., Mechoulam, R., & Martínez-Orgado, J. A. (2012) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2012.04341.x · Cited by 364
Changes in delta‐9‐tetrahydrocannabinol (THC) and cannabidiol (CBD) concentrations in cannabis over time: systematic review and meta‐analysis
Freeman, T. P., Craft, S., Wilson, J., Stylianou, S., ElSohly, M. A., Forti, M. D., & Lynskey, M. T. (2020) · Addiction · doi:10.1111/add.15253 · Cited by 353
Traditional marijuana, high‐potency cannabis and synthetic cannabinoids: increasing risk for psychosis
Murray, R. M., Quigley, H., Quattrone, D., Englund, A., & Forti, M. D. (2016) · World Psychiatry · doi:10.1002/wps.20341 · Cited by 332
Examining the profile of high-potency cannabis and its association with severity of cannabis dependence
Freeman, T. P., & WINSTOCK, A. R. (2015) · Psychological Medicine · doi:10.1017/s0033291715001178 · Cited by 326
Effects of Cannabis on Neurocognitive Functioning: Recent Advances, Neurodevelopmental Influences, and Sex Differences
Crane, N. A., Schuster, R. M., Fusar‐Poli, P., & González, R. (2012) · Neuropsychology Review · doi:10.1007/s11065-012-9222-1 · Cited by 330
Synthetic cannabinoid JWH-018 and psychosis: An explorative study
Every‐Palmer, S. (2011) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2011.01.012 · Cited by 300
A systematic review of the antipsychotic properties of cannabidiol in humans
Iseger, T. A., & Bossong, M. G. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.01.033 · Cited by 261
The adverse health effects of synthetic cannabinoids with emphasis on psychosis-like effects
van Amsterdam, J., Brunt, T., & van den Brink, W. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881114565142 · Cited by 244
The effects of cannabidiol (CBD) on cognition and symptoms in outpatients with chronic schizophrenia a randomized placebo controlled trial
Boggs, D. L., Surti, T. S., Gupta, A., Gupta, S., Niciu, M. J., Pittman, B. P., Martin, A. M. S., Thurnauer, H., Davies, A., D’Souza, D. C., et al. (2018) · Psychopharmacology · doi:10.1007/s00213-018-4885-9 · Cited by 256
Does Cannabidiol Protect Against Adverse Psychological Effects of THC?
Niesink, R. J. M., & van Laar, M. (2013) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2013.00130 · Cited by 253
Clinical and Preclinical Evidence for Functional Interactions of Cannabidiol and Δ9-Tetrahydrocannabinol
Boggs, D. L., Nguyen, J. D., Morgenson, D., Taffe, M. A., & Ranganathan, M. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.209 · Cited by 250
The neuropsychopharmacology of cannabis: A review of human imaging studies
Bloomfield, M., Hindocha, C., Green, S. F., Wall, M. B., Lees, R., Petrilli, K., Costello, H., Ogunbiyi, O., Bossong, M. G., & Freeman, T. P. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.10.006 · Cited by 247
A critical review of the antipsychotic effects of cannabidiol: 30 years of a translational investigation
Waldo Zuardi, A., Alexandre S. Crippa, J., E.C. Hallak, J., Bhattacharyya, S., Atakan, Z., Martin-Santos, R., K. McGuire, P., & Silveira Guimaraes, F. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212802884681 · Cited by 222
How does cannabidiol (CBD) influence the acute effects of delta-9-tetrahydrocannabinol (THC) in humans? A systematic review
Freeman, A. M., Petrilli, K., Lees, R., Hindocha, C., Mokrysz, C., Curran, H. V., Saunders, R., & Freeman, T. P. (2019) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2019.09.036 · Cited by 232
‘Standard THC units’: a proposal to standardize dose across all cannabis products and methods of administration
Freeman, T. P., & Lorenzetti, V. (2019) · Addiction · doi:10.1111/add.14842 · Cited by 222
The Role of cannabinoids in neuroanatomic alterations in cannabis users.
Lorenzetti, V., Solowij, N., & Yücel, M. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.11.013 · Cited by 208
Cannabinoid- and lysophosphatidylinositol-sensitive receptor GPR55 boosts neurotransmitter release at central synapses
Sylantyev, S., Jensen, T. P., Ross, R. A., & Rusakov, D. A. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1211204110 · Cited by 219
Medicinal use of cannabis based products and cannabinoids
Freeman, T. P., Hindocha, C., Green, S. F., & Bloomfield, M. (2019) · BMJ · doi:10.1136/bmj.l1141 · Cited by 225
Cannabidiol potentiates Δ9-tetrahydrocannabinol (THC) behavioural effects and alters THC pharmacokinetics during acute and chronic treatment in adolescent rats
Klein, C., Karanges, E., Spiro, A., Wong, A., Spencer, J., Huynh, T., Gunasekaran, N., Karl, T., Long, L. E., Huang, X.-F., et al. (2011) · Psychopharmacology · doi:10.1007/s00213-011-2342-0 · Cited by 206
Sub-chronic impact of cannabinoids in street cannabis on cognition, psychotic-like symptoms and psychological well-being
Morgan, C. J. A., Gardener, C., Schafer, G., Swan, S., Demarchi, C., Freeman, T. P., Warrington, P., Rupasinghe, I., Ramoutar, A., Tan, N., et al. (2012) · Psychological Medicine · doi:10.1017/s0033291711001322 · Cited by 195
Cannabidiol enhances consolidation of explicit fear extinction in humans
Das, R., Kamboj, S. K., Ramadas, M., Yogan, K., Gupta, V., Redman, E., Curran, H. V., & Morgan, C. J. A. (2013) · Psychopharmacology · doi:10.1007/s00213-012-2955-y · Cited by 200
Acute effects of delta-9-tetrahydrocannabinol, cannabidiol and their combination on facial emotion recognition: A randomised, double-blind, placebo-controlled study in cannabis users
Hindocha, C., Freeman, T. P., Schäfer, G., Gardener, C., Das, R., Morgan, C. J. A., & Curran, H. V. (2014) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2014.11.014 · Cited by 192
Analysis of Cannabis Seizures in NSW, Australia: Cannabis Potency and Cannabinoid Profile
Swift, W., Wong, A. C. H., Li, K. M., Arnold, J. C., & McGregor, I. S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070052 · Cited by 185
Cannabidiol (CBD) content in vaporized cannabis does not prevent tetrahydrocannabinol (THC)-induced impairment of driving and cognition
Arkell, T. R., Lintzeris, N., Kevin, R. C., Ramaekers, J. G., Vandrey, R. G., Irwin, C. G., Haber, P., & McGregor, I. S. (2019) · Psychopharmacology · doi:10.1007/s00213-019-05246-8 · Cited by 182
The Endocannabinoid System, Cannabinoids, and Pain
Fine, P. G., & Rosenfeld, M. J. (2013) · Rambam Maimonides Medical Journal · doi:10.5041/rmmj.10129 · Cited by 213
Acute and chronic effects of cannabinoids on effort-related decision-making and reward learning: an evaluation of the cannabis ‘amotivational’ hypotheses
Lawn, W., Freeman, T. P., Pope, R. A., Joye, A., Harvey, L. A., Hindocha, C., Mokrysz, C., Moss, A., Wall, M. B., Bloomfield, M., et al. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4383-x · Cited by 182
Cannabinoids in attention-deficit/hyperactivity disorder: A randomised-controlled trial
Cooper, R. E., Williams, E., Seegobin, S., Tye, C., Kuntsi, J., & Asherson, P. J. (2017) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2017.05.005 · Cited by 180
A randomised controlled trial of vaporised Δ9-tetrahydrocannabinol and cannabidiol alone and in combination in frequent and infrequent cannabis users: acute intoxication effects
Solowij, N., Broyd, S. J., Greenwood, L., van Hell, H., Martelozzo, D., Rueb, K., Todd, J., Liu, Z., Galettis, P., Martin, J. H., et al. (2019) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-019-00978-2 · Cited by 176
Cannabidiol (CBD) use in psychiatric disorders: A systematic review
Bonaccorso, S., Ricciardi, A., Zangani, C., Chiappini, S., & Schifano, F. (2019) · NeuroToxicology · doi:10.1016/j.neuro.2019.08.002 · Cited by 180
Early Phase in the Development of Cannabidiol as a Treatment for Addiction: Opioid Relapse Takes Initial Center Stage
Hurd, Y. L., Yoon, M. J., Manini, A. F., Hernandez, S. H., Olmedo, R., Östman, M., & Jutras‐Aswad, D. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0373-7 · Cited by 171
Considering Cannabis: The Effects of Regular Cannabis Use on Neurocognition in Adolescents and Young Adults
Lisdahl, K. M., Wright, N. E., Medina-Kirchner, C., Maple, K. E., & Shollenbarger, S. (2014) · Current Addiction Reports · doi:10.1007/s40429-014-0019-6 · Cited by 160
Mapping cannabis potency in medical and recreational programs in the United States
Cash, M. C., Cunnane, K., Fan, C., & Romero-Sandoval, E. A. (2020) · PLoS ONE · doi:10.1371/journal.pone.0230167 · Cited by 154
Adolescent exposure to cannabis as a risk factor for psychiatric disorders
Rubino, T., Zamberletti, E., & Parolaro, D. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881111405362 · Cited by 156
Can we make cannabis safer?
Englund, A., Freeman, T. P., Murray, R. M., & McGuire, P. K. (2017) · The Lancet Psychiatry · doi:10.1016/s2215-0366(17)30075-5 · Cited by 156
Cannabis, cannabidiol, and epilepsy — From receptors to clinical response
Szaflarski, J. P., & Bebin, E. M. (2014) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2014.08.135 · Cited by 150
A systematic review of the effect of cannabidiol on cognitive function: Relevance to schizophrenia
Osborne, A. L., Solowij, N., & Weston–Green, K. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.11.012 · Cited by 154
Effect of Cannabidiol on Medial Temporal, Midbrain, and Striatal Dysfunction in People at Clinical High Risk of Psychosis: A Randomized Clinical Trial
Bhattacharyya, S., Wilson, R., Appiah-Kusi, E., O'Neill, A., Brammer, M., Perez, J., Murray, R., Allen, P., Bossong, M., & McGuire, P. (2018) · JAMA psychiatry · doi:10.1001/jamapsychiatry.2018.2309 · Cited by 134
The Cannabinoid Content of Legal Cannabis in Washington State Varies Systematically Across Testing Facilities and Popular Consumer Products
Jikomes, N., & Zoorob, M. J. (2018) · Scientific Reports · doi:10.1038/s41598-018-22755-2 · Cited by 141
Just say ‘know’: how do cannabinoid concentrations influence users' estimates of cannabis potency and the amount they roll in joints?
Freeman, T. P., Morgan, C. J. A., Hindocha, C., Schäfer, G., Das, R., & Curran, H. V. (2014) · Addiction · doi:10.1111/add.12634 · Cited by 140
Current Status and Prospects for Cannabidiol Preparations as New Therapeutic Agents
Fasinu, P. S., Phillips, S., ElSohly, M. A., & Walker, L. (2016) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1780 · Cited by 140
Cannabidiol in medical marijuana: Research vistas and potential opportunities
Rong, C., Lee, Y. L., Carmona, N. E., Cha, D. S., Ragguett, R., Rosenblat, J. D., Mansur, R. B., Ho, R., & McIntyre, R. S. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.05.005 · Cited by 140
Individual and combined effects of acute delta-9-tetrahydrocannabinol and cannabidiol on psychotomimetic symptoms and memory function
Morgan, C. J. A., Freeman, T. P., Hindocha, C., Schäfer, G., Gardner, C., & Curran, H. V. (2018) · Translational Psychiatry · doi:10.1038/s41398-018-0191-x · Cited by 140
Does Cannabis Composition Matter? Differential Effects of Delta-9-tetrahydrocannabinol and Cannabidiol on Human Cognition
Colizzi, M., & Bhattacharyya, S. (2017) · Current Addiction Reports · doi:10.1007/s40429-017-0142-2 · Cited by 138
Cannabidiol as an Intervention for Addictive Behaviors: A Systematic Review of the Evidence
Prud'homme, M., Cata, R., & Jutras‐Aswad, D. (2015) · Substance Abuse Research and Treatment · doi:10.4137/sart.s25081 · Cited by 133
Increasing potency and price of cannabis in Europe, 2006–16
Freeman, T. P., Groshkova, T., Cunningham, A., Sedefov, R., Griffiths, P., & Lynskey, M. T. (2018) · Addiction · doi:10.1111/add.14525 · Cited by 133
Cannabidiol inhibits the reward‐facilitating effect of morphine: involvement of 5‐HT1A receptors in the dorsal raphe nucleus
Katsidoni, V., Anagnostou, I., & Panagis, G. (2012) · Addiction Biology · doi:10.1111/j.1369-1600.2012.00483.x · Cited by 132
Therapeutic Effects of Prolonged Cannabidiol Treatment on Psychological Symptoms and Cognitive Function in Regular Cannabis Users: A Pragmatic Open-Label Clinical Trial
Solowij, N., Broyd, S. J., Beale, C., Prick, J.-A., Greenwood, L., van Hell, H., Suo, C., Galettis, P., Pai, N. B., Fu, S., et al. (2018) · Cannabis and Cannabinoid Research · doi:10.1089/can.2017.0043 · Cited by 130
Cannabis, a cause for anxiety? A critical appraisal of the anxiogenic and anxiolytic properties
Sharpe, L., Sinclair, J., Kramer, A., de Manincor, M., & Sarris, J. J. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02518-2 · Cited by 129
Current Therapeutic Cannabis Controversies and Clinical Trial Design Issues
Russo, E. B. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00309 · Cited by 128
Biphasic effects of THC in memory and cognition
Calabrese, E. J., & Rubio‐Casillas, A. (2018) · European Journal of Clinical Investigation · doi:10.1111/eci.12920 · Cited by 132
Chronic Adolescent Δ 9 -Tetrahydrocannabinol Treatment of Male Mice Leads to Long-Term Cognitive and Behavioral Dysfunction, Which Are Prevented by Concurrent Cannabidiol Treatment
Murphy, M. N., Mills, S., Winstone, J., Leishman, E., Wager‐Miller, J., Bradshaw, H. B., & Mackie, K. (2017) · Cannabis and Cannabinoid Research · doi:10.1089/can.2017.0034 · Cited by 131
Therapeutic potential of cannabinoid medicines
Robson, P. (2013) · Drug Testing and Analysis · doi:10.1002/dta.1529 · Cited by 126
Cannabinoid Modulation of Functional Connectivity within Regions Processing Attentional Salience
Bhattacharyya, S., Falkenberg, I., Martín‐Santos, R., Atakan, Z., Crippa, J. A. S., Giampietro, V., Brammer, M. J., & McGuire, P. K. (2014) · Neuropsychopharmacology · doi:10.1038/npp.2014.258 · Cited by 114
Cannabidiol as a potential treatment for psychosis
Davies, C., & Bhattacharyya, S. (2019) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125319881916 · Cited by 121
Replication in two independent population-based samples that childhood maltreatment and cannabis use synergistically impact on psychosis risk
Konings, M., Stefanis, N. C., Kuepper, R., de Graaf, R., ten Have, M., van Os, J., Bakoula, C., & Henquet, C. (2011) · Psychological Medicine · doi:10.1017/s0033291711000973 · Cited by 109
Are adolescents more vulnerable to the harmful effects of cannabis than adults? A placebo-controlled study in human males
Mokrysz, C., Freeman, T. P., Korkki, S. M., Griffiths, K., & Curran, H. V. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.225 · Cited by 107
Cerebrospinal fluid anandamide levels, cannabis use and psychotic-like symptoms
Morgan, C. J. A., Page, E., Schaefer, C., Chatten, K., Manocha, A., Gulati, S., Curran, H. V., Brandner, B., & Leweke, F. M. (2013) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.112.121178 · Cited by 106
AKT1 genotype moderates the acute psychotomimetic effects of naturalistically smoked cannabis in young cannabis smokers
Morgan, C. J. A., Freeman, T. P., Powell, J. F., & Curran, H. V. (2016) · Translational Psychiatry · doi:10.1038/tp.2015.219 · Cited by 101
Deconstructing the neurobiology of cannabis use disorder
Ferland, J. N., & Hurd, Y. L. (2020) · Nature Neuroscience · doi:10.1038/s41593-020-0611-0 · Cited by 104
Cannabidiol as a potential treatment for psychosis
Schubart, C. D., Sommer, I. E., Fusar‐Poli, P., de Witte, L. D., Kahn, R. S., & Boks, M. P. (2013) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2013.11.002 · Cited by 105
Associations of Social Phobia and General Anxiety with Alcohol and Drug Use in A Community Sample of Adolescents
Fröjd, S. A., Ranta, K., Kaltiala‐Heino, R., & MARTTUNEN, M. J. (2011) · Alcohol and Alcoholism · doi:10.1093/alcalc/agq096 · Cited by 99
The Association between Regular Cannabis Exposure and Alterations of Human Brain Morphology: An Updated Review of the Literature
Lorenzetti, V., Solowij, N., Fornito, A., Lubman, D. I., & Yücel, M. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990435 · Cited by 99
Does cannabidiol make cannabis safer? A randomised, double-blind, cross-over trial of cannabis with four different CBD:THC ratios
Englund, A., Oliver, D., Chesney, E., Chester, L. A., Wilson, J., Sovi, S., Micheli, A. D., Hodsoll, J. P., Fusar‐Poli, P., Strang, J., et al. (2022) · Neuropsychopharmacology · doi:10.1038/s41386-022-01478-z · Cited by 96
The molecular mechanisms that underpin the biological benefits of full-spectrum cannabis extract in the treatment of neuropathic pain and inflammation
Maayah, Z. H., Takahara, S., Ferdaoussi, M., & Dyck, J. R. B. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2020.165771 · Cited by 103
United Kingdom drug situation: annual report to the European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) 2012.
Davies, C., English, L., Stewart, C. R., Edginton, M., McVeigh, J., & Bellis, M. A. (2013) · Cited by 91
Memory-rescuing effects of cannabidiol in an animal model of cognitive impairment relevant to neurodegenerative disorders
Fagherazzi, E. V., Garcia, V. A., Maurmann, N., Bervanger, T., Halmenschlager, L. H., Busato, S. B., Hallak, J. E., Zuardi, A. W., Crippa, J. A., & Schröder, N. (2012) · Psychopharmacology · doi:10.1007/s00213-011-2449-3 · Cited by 87
The effect of five day dosing with THCV on THC-induced cognitive, psychological and physiological effects in healthy male human volunteers: A placebo-controlled, double-blind, crossover pilot trial
Englund, A., Atakan, Z., Kralj, A., Tunstall, N., Murray, R. M., & Morrison, P. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881115615104 · Cited by 87
Effects of Δ9-THC and cannabidiol vapor inhalation in male and female rats
Paydar, M. J., Nguyen, J. D., Kerr, T. M., Grant, Y., Vandewater, S. A., Cole, M., & Taffe, M. A. (2018) · Psychopharmacology · doi:10.1007/s00213-018-4946-0 · Cited by 82
Cannabis and development of dual diagnoses: A literature review
Hanna, R. C., Perez, J. M., & Ghose, S. (2016) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2016.1213273 · Cited by 93
Harms and benefits associated with psychoactive drugs: findings of an international survey of active drug users
Morgan, C. J. A., Noronha, L. A., Muetzelfeldt, M., Feilding, A., & Curran, H. V. (2013) · Journal of Psychopharmacology · doi:10.1177/0269881113477744 · Cited by 92
Neuropharmacological Effects of the Main Phytocannabinoids: A Narrative Review
SANTOS, R. G. D., Hallak, J. E. C., & Crippa, J. A. S. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-57369-0_3 · Cited by 82
An Atmospheric Pressure Chemical Ionization MS/MS Assay Using Online Extraction for the Analysis of 11 Cannabinoids and Metabolites in Human Plasma and Urine
Klawitter, J., Sempio, C., Mörlein, S., Bloois, E. D., Klepacki, J., Henthorn, T. K., Leehey, M. A., Hoffenberg, E. J., Knupp, K. G., Wang, G. S., et al. (2017) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0000000000000427 · Cited by 80
Splendor in the Grass? A Pilot Study Assessing the Impact of Medical Marijuana on Executive Function
Gruber, S. A., Sagar, K. A., Dahlgren, M. K., Racine, M. T., Smith, R. T., & Lukas, S. E. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00355 · Cited by 86
Cannabis and Cognitive Functioning: From Acute to Residual Effects, From Randomized Controlled Trials to Prospective Designs
Bourque, J., & Potvin, S. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.596601 · Cited by 96
Cannabidiol fails to reverse hypothermia or locomotor suppression induced by Δ9‐tetrahydrocannabinol in S prague‐ D awley rats
Taffe, M. A., Creehan, K. M., & Vandewater, S. A. (2014) · British Journal of Pharmacology · doi:10.1111/bph.13024 · Cited by 77
The evolving science of phytocannabinoids
Reekie, T. A., Scott, M., & Kassiou, M. (2017) · Nature Reviews Chemistry · doi:10.1038/s41570-017-0101 · Cited by 78
Role of Cannabidiol in the Therapeutic Intervention for Substance Use Disorders
Navarrete, F., García‐Gutiérrez, M. S., Gasparyan, A., Austrich-Olivares, A., & Manzanares, J. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.626010 · Cited by 81
Acute and Non-acute Effects of Cannabis on Human Memory Function: A Critical Review of Neuroimaging Studies
Bossong, M. G., Jager, G., Bhattacharyya, S., & Allen, P. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113199990436 · Cited by 75
Cannabidiol attenuates deficits of visuospatial associative memory induced by Δ9tetrahydrocannabinol
Wright, M. J., Vandewater, S. A., & Taffe, M. A. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12199 · Cited by 72
Comparison of cannabinoids in hair with self-reported cannabis consumption in heavy, light and non-cannabis users
Taylor, M., Lees, R., Henderson, G., Lingford‐Hughes, A., Macleod, J., Sullivan, J., & Hickman, M. (2017) · Drug and Alcohol Review · doi:10.1111/dar.12412 · Cited by 69
Medical Cannabis in Children
Aran, A. A., & Cayam-Rand, D. (2020) · Rambam Maimonides Medical Journal · doi:10.5041/rmmj.10386 · Cited by 70
Psychoactive constituents of cannabis and their clinical implications: a systematic review
Casajuana, C., López‐Pelayo, H., Balcells‐Oliveró, M., Colom, J., & Gual, A. (2017) · Adicciones · doi:10.20882/adicciones.858 · Cited by 64
The Grass Might Be Greener: Medical Marijuana Patients Exhibit Altered Brain Activity and Improved Executive Function after 3 Months of Treatment
Gruber, S. A., Sagar, K. A., Dahlgren, M. K., Gönenç, A., Smith, R. T., Lambros, A. M., Cabrera, K. B., & Lukas, S. E. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00983 · Cited by 65
Which biological and self-report measures of cannabis use predict cannabis dependency and acute psychotic-like effects?
Curran, H. V., Hindocha, C., Morgan, C. J. A., Shaban, N. D. C., Das, R., & Freeman, T. P. (2018) · Psychological Medicine · doi:10.1017/s003329171800226x · Cited by 64
Cannabinergic Pain Medicine: A Concise Clinical Primer and Survey of Randomized-controlled Trial Results
Aggarwal, S. K. (2013) · The Clinical Journal of Pain · doi:10.1097/ajp.0b013e31824c5e4c · Cited by 62
Decoding the Postulated Entourage Effect of Medicinal Cannabis: What It Is and What It Isn’t
Christensen, C., Rose, M., Cornett, C., & Allesø, M. (2023) · Biomedicines · doi:10.3390/biomedicines11082323 · Cited by 75
Enhanced Brain Disposition and Effects of Δ9-Tetrahydrocannabinol in P-Glycoprotein and Breast Cancer Resistance Protein Knockout Mice
Spiro, A. S., Wong, A., Boucher, A. A., & Arnold, J. C. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035937 · Cited by 61
Psychological and psychosocial interventions for cannabis cessation in adults: a systematic review short report
Cooper, K. L., Chatters, R., Kaltenthaler, E., & Wong, R. (2015) · Health Technology Assessment · doi:10.3310/hta19560 · Cited by 63
Role of Cannabinoids in Pain Management
Russo, E. B., & Hohmann, A. G. (2012) · Springer eBooks · doi:10.1007/978-1-4614-1560-2_18 · Cited by 62

Authors: Morgan, C. J. A., Schafer, G., Freeman, T. P., & Curran, H. V.
Affiliations: University College London (GB)
Corresponding author: Curran, H. Valerie
ORCID: Morgan, Celia J. A.
Freeman, Tom P.
Curran, H. Valerie
Venue: British Journal of Psychiatry
Publisher: Royal College of Psychiatrists
Published: 2010-10
Volume: 197
Issue: 4
Pages: 285-290
ISSN: 0007-1250 (ISSN-L)
1472-1465
DOI: 10.1192/bjp.bp.110.077503
OpenAlex: W2015441565
Cited by: 305
References: 30
Citations by year: 2026: 4 · 2025: 11 · 2024: 8 · 2023: 23 · 2022: 13 · 2021: 20 · 2020: 31 · 2019: 24 · 2018: 26 · 2017: 25 · 2016: 22 · 2015: 20 · 2014: 20 · 2013: 17 · 2012: 23
FWCI: 13.45
Type: journal article
Language: en
Open access: bronze
doi.org
Licence: www.cambridge.org/core/terms (unspecified, 2650 d)
Locations: The British Journal of Psychiatry (publishedVersion)
PubMed (publishedVersion)
Funders: Medical Research Council
Topics: Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
Keywords: cannabidiol, delta-9-tetrahydrocannabinol, cannabis smoking, psychotomimetic effects, CB1 receptor antagonism, harm reduction, prose recall, cannabis users
MeSH terms: Adolescent, Alcohol Drinking, Analysis of Variance, Cannabidiol, Cannabinoids, Female, United Kingdom, Humans, Male, Marijuana Smoking, Memory, Memory Disorders, Psychiatric Status Rating Scales, Mental Recall, Saliva, Dronabinol, Verbal Learning, Receptor, Cannabinoid, CB1, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Impact of cannabidiol on the acute memory and psychotomimetic effects of smoked cannabis: naturalistic study

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks